IR Medtek
IR Medtek, founded in 2019, is a US-based medical device company specializing in innovative healthcare solutions.
Founded
2019IR Medtek, founded in 2019, is a US-based medical device company specializing in innovative healthcare solutions.
IR Medtek, founded in 2019 in Gahanna, Ohio, is a medical device company specializing in real-time, noninvasive cancer detection technology. The company was established by Doug Cohen, Andy Spector, and two other co-founders in collaboration with the Ohio State Innovation Fund. IR Medtek's core mission is to revolutionize cancer diagnostics through advanced, noninvasive methods, aiming to improve early detection and patient outcomes. Their primary product leverages technology developed at The Ohio State University and The James Cancer Hospital.
Notable affiliated individuals include co-founders Doug Cohen and Andy Spector. The company has achieved significant milestones by securing exclusive licensing for its innovative technology from The Ohio State University. This partnership underscores their commitment to cutting-edge research and development. IR Medtek's impact is marked by its potential to transform cancer diagnostics, offering a less invasive and more efficient alternative to traditional methods, thereby enhancing early detection and treatment efficacy.
Companies similar to IR Medtek include Cellens, OmnEcoil Instruments, bTECH and O2M Technologies.
IR Medtek was founded in 2019.
IR Medtek's headquarters is located in Gahanna, OH, US.
IR Medtek's most recent funding round was for $900k (USD) in December 2021.
As of Dec 17, 2021, IR Medtek has disclosed funding of $1.4M (USD). Undisclosed round amounts are excluded.
IR Medtek has 5 employees as of Feb 5, 2024.
O2M Technologies
